Why does it seem to be so hard to understand what
Post# of 72440
Headline excerpt:
to Develop and Commercialize Brilacidin for Ulcerative Proctitis/Proctosigmoiditis
Quote:
for the treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis.
The non-binding term sheet also includes a Right of First Refusal for rights to Brilacidin for the treatment of more extensive forms of Inflammatory Bowel Disease, such as Ulcerative Colitis and Crohn’s Disease, and a Right of First Negotiation for rights to Brilacidin in other Gastrointestinal (GI) indications.
Link to complete release:
http://www.ipharminc.com/press-release/2019/5...igmoiditis